Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs.

Chiarella, Emanuela; Nisticò, Clelia; Di Vito, Anna; Morrone, Helen Linda; Mesuraca, Maria

Chiarella, Emanuela; Nisticò, Clelia; Di Vito, Anna; Morrone, Helen Linda; Mesuraca, Maria.

Afiliación

Chiarella E; Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
Nisticò C; Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
Di Vito A; Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
Morrone HL; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, University Magna Græcia, 88100 Catanzaro, Italy.
Mesuraca M; Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Biomedicines ; 10(5)2022 May 16.

Article en En | MEDLINE | ID: mdl-35625883

Palabras clave

AML; bisphosphonates; mevalonate pathway; protein isoprenylation; small GTPases

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google